Firms to develop freeze-dried human plasma

Entegrion and Kedrion Melville agreed to collaborate in the development and commercialization of the former's freeze-dried human plasma Resusix, a shelf-stable alternative to fresh-frozen plasma. The partners plan to initiate clinical studies this year. Kedrion will invest in Entegrion under the agreement.

View Full Article in:

American City Business Journals · WRALTechWire.com (Raleigh, N.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN